Merck, Schering Offer $42M To Settle Vytorin Suits
Pharmaceutical giants Merck & Co. and Schering-Plough Corp. have said they will pay $41.5 million to settle a host of civil lawsuits over joint marketing and studies of the cholesterol drug...To view the full article, register now.
Already a subscriber? Click here to view full article